Module 6: Technologies

NSWInvestigating ScienceSyllabus dot point

Inquiry Question 1: How does technology contribute to scientific research and how do scientific advancements enhance technology?

Investigate how technological developments have enhanced scientific research, including a research facility such as a nuclear reactor or synchrotron

A focused answer to the HSC Investigating Science Module 6 dot point on the OPAL research reactor at ANSTO. Covers what the reactor does, nuclear medicine production, neutron scattering, and worked HSC past exam questions on technology enabling science.

Generated by Claude OpusReviewed by Better Tuition Academy5 min answer

Have a quick question? Jump to the Q&A page

What this dot point is asking

NESA wants you to describe how a large-scale research facility enables scientific research that would otherwise be impossible, with a specific case study. The OPAL reactor at ANSTO is the recommended Australian example.

The answer

OPAL (Open Pool Australian Lightwater reactor) is Australia's national nuclear research reactor. Operated by ANSTO at Lucas Heights in southern Sydney since 2007, it produces nuclear medicine isotopes and provides neutron beams for materials research.

What OPAL is

OPAL is a 20 MW reactor that uses low-enriched uranium fuel (less than 20 per cent U-235, well below weapons-grade) cooled by light water. It replaced the older HIFAR reactor in 2007 and is one of about 50 research reactors operating worldwide. Importantly, OPAL is not a power reactor: it does not generate electricity. Its purpose is to produce neutrons.

What neutrons can do

Neutrons are neutral subatomic particles produced in the reactor's core. Two main uses:

1. Probing materials with neutron beams.

Unlike X-rays, neutrons pass through dense materials, are scattered by light elements like hydrogen and reveal atomic positions, magnetic moments and atomic vibrations. Eight neutron-beam instruments at OPAL serve fields from drug design to battery research.

Specific instruments at OPAL include:

  • WOMBAT. A high-intensity diffractometer for fast atomic structure determination.
  • KOWARI. A residual stress diffractometer used for engineering components and welds.
  • PELICAN. Time-of-flight spectrometer for dynamics of magnetic and quantum materials.
  • PLATYPUS. Reflectometer for thin films and interfaces.

2. Transmuting targets to produce radioisotopes.

Materials placed in the reactor are bombarded with neutrons, which converts stable isotopes into useful radioisotopes.

Nuclear medicine production

OPAL is the only Australian source of medical radioisotopes.

Isotope Use Production
Molybdenum-99 (decays to technetium-99m) Diagnostic imaging of heart, bone, brain Approximately 10,000 doses/week
Iodine-131 Treatment of thyroid cancer Targeted radiotherapy
Lutetium-177 Treatment of neuroendocrine and prostate cancer Targeted radiotherapy
Yttrium-90 Treatment of liver cancer Targeted radiotherapy

Technetium-99m alone is used in 80 per cent of all nuclear medicine procedures globally. About 700,000 scans per year in Australia depend on OPAL.

Other applications

Silicon transmutation doping
Pure silicon ingots are irradiated to convert a small fraction to phosphorus, producing semiconductor-grade silicon used in high-voltage electronics for solar arrays and electric vehicles. OPAL is one of the world's largest commercial doping services.
Neutron activation analysis
Trace elements can be detected at parts-per-billion sensitivity by activating samples and measuring the gamma rays emitted. Used for forensic science, archaeology and environmental monitoring.
Indigenous artefact analysis
Researchers have used OPAL's neutron techniques to study Aboriginal ochre samples and stone tools, identifying trade routes and pigment sources across the continent.

Scientific output

About 700 visiting scientists from Australian and international universities use OPAL's beam instruments each year. Output includes:

  • Lithium-ion battery materials. Neutron diffraction of cathode materials at the University of Wollongong and ARC Centres of Excellence.
  • Mining waste characterisation. Neutron techniques for tracking heavy-metal contamination.
  • Pharmaceutical research. Drug crystal structure determination.
  • Climate science. Ice-core dating using neutron activation.

Strategic and policy context

ANSTO's OPAL gives Australia:

  • Independence from overseas supply of molybdenum-99. The Canadian NRU reactor (a major global supplier) shut down in 2018, causing global shortages. OPAL has helped stabilise supply.
  • A neutron-science capability that universities cannot afford to build individually.
  • A national nuclear science training facility.

Controversies

  • Safety. OPAL is licensed by the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) and operates to international Atomic Energy Agency (IAEA) safeguards.
  • Waste. Spent fuel is sent to France for reprocessing under a long-term agreement; intermediate-level waste remains at Lucas Heights pending a National Radioactive Waste Management Facility, which has been politically contested.
  • Cost. OPAL cost approximately 400 million AUD to build, and ANSTO's annual budget is around 250 million AUD per year. Critics argue the cost is high relative to other research-funding options; supporters cite the irreplaceable medical isotope supply.

Past exam questions, worked

Real questions from past NESA papers on this dot point, with our answer explainer.

2023 HSC5 marksDescribe how a research facility has enabled scientific research, using a specific example.
Show worked answer →

A 5-mark answer needs the facility, its capabilities, examples of research enabled and the broader impact.

Facility. The OPAL (Open Pool Australian Lightwater) research reactor at the Australian Nuclear Science and Technology Organisation (ANSTO) Lucas Heights, Sydney. Operational since 2007 and replaced the HIFAR reactor.

Capabilities.

  • Neutron beams for materials science. Neutrons probe materials at the atomic scale and reveal magnetic, structural and dynamic properties impossible to image otherwise.
  • Radioisotope production. OPAL is the only Australian source of molybdenum-99 (which decays to technetium-99m for medical imaging), iodine-131, lutetium-177 and other diagnostic and therapeutic isotopes.
  • Neutron activation analysis for trace element determination in environmental and archaeological samples.
  • Silicon doping. Producing semiconductor-grade silicon for the electronics industry.

Research enabled. Materials research on lithium-ion batteries, magnetic shape-memory alloys, archaeological dating of Aboriginal artefacts, climate proxy research in ice cores.

Broader impact.

  • 10,000+ nuclear medicine doses produced weekly for hospitals.
  • Approximately 700 visiting scientists per year use the neutron beam facilities.
  • Trains the next generation of Australian nuclear scientists.

Markers reward the named facility, multiple research applications and quantified impact.

2021 HSC4 marksExplain how nuclear medicine produced at OPAL contributes to medical diagnosis in Australia.
Show worked answer →

A 4-mark answer needs the production, the medical use, the patient impact and a quantified contribution.

Production
OPAL irradiates targets with neutrons to produce radioisotopes that cannot be made by other means. The key isotope is molybdenum-99, which decays to technetium-99m, the workhorse of nuclear medicine. ANSTO produces approximately 10,000 doses per week.
Medical use
Technetium-99m is attached to pharmaceutical molecules that target specific organs (bone, heart, kidneys, brain). It emits gamma rays detectable by gamma cameras, producing diagnostic images of organ function rather than just structure.
Patient impact
A bone scan can detect cancer metastases earlier than CT or MRI. A myocardial perfusion scan reveals heart-attack damage. Roughly 700,000 nuclear medicine scans per year in Australia rely on OPAL-produced isotopes.
Quantified contribution
ANSTO supplies 100 per cent of Australian molybdenum-99 demand and exports to over 20 countries. The reactor reduces Australia's dependence on overseas supply, which has been disrupted multiple times since 2010.

Markers reward the production process, the medical mechanism, named scans and quantified output.

Related dot points